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The accumulation of misfolded proteins is a fundamental
pathogenic process in neurodegenerative diseases.
However, the factors that trigger aggregation and spread-
ing of a-synuclein (a-syn), the principal component of the
intraneuronal inclusions known as Lewy bodies (LBs) and
Lewy neurites (LNs) that characterize Parkinson’s disease
(PD) and dementia with LBs (DLB) in brain are poorly
understood. We demonstrate that pre-formed fibrils (pffs)
generated from recombinant a-syn enter cultured primary
neurons generated from non-transgenic wildtype mice,
promote recruitment of soluble endogenous a-syn into
insoluble PD-like LBs and LNs. Accumulation of
pathologic a-syn led to selective decreases in synaptic
proteins, progressive impairments in neuronal excitability
and connectivity, and eventually, neuron death. Moreover,
we further show that in young asymptomatic a-syn
transgenic (Tg) mice, intracerebral injections of synthetic
a-syn pffs accelerate both the formation of intracellular
LB/LN-like inclusions and the onset of neurological symp-
toms in recipient animals. Pathologic a-syn propagated
along major central nervous system (CNS) pathways to
regions far beyond injection sites and dramatically reduced
survival with a highly reproducible interval from injection
to death in inoculated animals. Thus, synthetic a-Syn pffs
are wholly sufficient to initiate PD-like LBs/LNs and to
transmit disease in primary neurons in vitro and Tg mice
in vivo. Thus, these data support a prion-like cascade
in synucleinopathies whereby cell-to-cell transmission
and propagation of misfolded a-syn underlie the CNS
proliferation of LBs/LNs. These findings open up new
avenues for understanding the progression of PD and for
developing novel therapeutics.
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